Page last updated: 2024-08-23

moexiprilat and ramipril

moexiprilat has been researched along with ramipril in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busse, R; Dambacher, T; Hecker, M1
Busse, R; Fleming, I; Hecker, M1
Bara, AT; Busse, R; Hecker, M; Pörsti, I1
Bara, AT; Busse, R; Hecker, M2

Other Studies

5 other study(ies) available for moexiprilat and ramipril

ArticleYear
Role of endothelium-derived bradykinin in the control of vascular tone.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium; Cells, Cultured; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Female; Humans; Isoquinolines; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Rabbits; Ramipril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Vasodilation

1992
Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 5

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Calcium; Cattle; Cells, Cultured; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Humans; Isoquinolines; Nitric Oxide; Nitroarginine; Ramipril; Tetrahydroisoquinolines; Umbilical Veins; Vasodilation

1993
Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    British journal of pharmacology, 1994, Volume: 111, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Epoprostenol; Female; In Vitro Techniques; Isoquinolines; Jugular Veins; Male; Oligopeptides; Prostaglandin Endoperoxides, Synthetic; Rabbits; Ramipril; Receptors, Bradykinin; Tetrahydroisoquinolines; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

1994
Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    European heart journal, 1993, Volume: 14 Suppl I

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Cattle; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Nitric Oxide; Nitroarginine; Ramipril; Tetrahydroisoquinolines; Vasodilation

1993
Potentiation of the biological efficacy of bradykinin by ACE inhibitors: a shift in the affinity of the B2 receptor?
    Immunopharmacology, 1996, Volume: 33, Issue:1-3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Drug Synergism; In Vitro Techniques; Isoquinolines; Jugular Veins; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Ramipril; Rats; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrahydroisoquinolines; Vasoconstriction

1996